Biotech

All Articles

Former Seagen chief executive officer reveals brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer in 2013 for an ...

Ironwood makes additional purpose $1B GI medicine with new subgroup information

.On the heels of a period 3 gain that fell short to make an impression on financiers, Ironwood Pharm...

Novartis inks $150M offer for autoimmune molecular adhesive

.Do not quit Monte Rosa Therapies right now. The Boston-based biotech is actually enjoying after sig...

Jade carves out director staff along with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and reti...

Septerna goes public with upsized offering of $288M

.Celebrating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...

AbbVie makes Richter wealthier, paying out $25M to make up discovery pact

.AbbVie has returned to the source of its antipsychotic goliath Vraylar seeking an additional smash ...

GenSight goes into final weeks of cash path as profits flow noses out of grasp

.GenSight Biologics is weeks off of running out of loan. Once more. The biotech just has adequate mo...

AZ licenses thrown out uncommon health condition drug to Monopar Rehabs

.Monopar Rehabs is recouping a medicine from the scrap heap of AstraZeneca's rare illness pipeline. ...

Arcus' new HIF-2a information in renal cancer cells mention potential advantage over Merck's Welireg, experts state

.Along with brand-new information out on Arcus Biosciences' experimental HIF-2a prevention, one grou...

Roche wagers approximately $1B to grow Dyno gene therapy shipping pact

.After creating a genetics therapy partnership with Dyno Rehabs in 2020, Roche is back for more.In a...